来自MSN9 个月
FDA and EMA team up to expedite complex generic drug development
In a move to enhance patient access to complex generic drugs, the FDA's Office of Generic Drugs (OGD) and the EMA have joined forces in a new pilot programme. This initiative, an extension of the ...